# A 2-Month Safety Follow-Up Trial

> **NCT00741429** · — · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 649 (actual)

## Conditions studied

- Type 1 Diabetes
- Type 2 Diabetes

## Interventions

- **DRUG:** Technosphere Insulin Inhalation Powder
- **DRUG:** Comparator

## Key facts

- **NCT ID:** NCT00741429
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 649 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741429, "A 2-Month Safety Follow-Up Trial". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00741429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*